Novo Nordisk says it has not yet posted details about new CagriSema trial
ReutersJan 30, 2025 3:27 PM
LONDON, Jan 30 (Reuters) - Novo Nordisk NOVOb.CO said on Thursday it has not yet posted details about a new trial of its experimental next-generation obesity drug CagriSema, which it announced it would start after late-stage trial data in December disappointed the market.
Reuters reported earlier on Thursday that the Danish drugmaker will launch a new Phase III trial of the weekly injection on Feb. 10.
That trial will study the long-term efficacy of CagriSema and was already planned as part of the REDEFINE series, a spokesperson said.
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
Understanding Token Burning: Why Crypto Projects Destroy Their Own Coins
Token burning is the permanent removal of cryptocurrency from circulation, similar to stock buybacks in traditional finance. Tokens are sent to a “burn address” or “blackhole address” — wallets with no private key access — making them unrecoverable and unusable.TradingKey
Sat, Aug 16
Bridgewater Associates Q2 2025 13F Analysis: Founder Ray Dalio’s Final Act
TradingKey - Bridgewater Associates, the world’s largest hedge fund and renowned for its macroeconomic analysis, continues to command market respect with its “risk parity” strategy and precise economic cycle timing.TradingKey
Thu, Aug 14
U.S. July CPI Commentary: Obstacles Cleared, Where Will U.S. Stocks Go Next?
TradingKey - On 12 August 2025, the United States released its Consumer Price Index (CPI) data for July. In terms of headline inflation, the CPI rose by 2.7% year-on-year in the month, slightly lower than the expected 2.8%. However, core CPI climbed 3.1% year-on-year, edging past the projected 3.0%.TradingKey
Wed, Aug 13
Ethereum Price Prediction: Will ETH Extend the Rally? What’s the Future Trend?
Ethereum's impressive 2025 rally has been largely fueled by inflows from spot ETFs and a surge in institutional holdings, signaling growing confidence in its role as a core asset in the crypto market. However, to officially confirm the start of a new bull cycle, ETH must break above the critical $4,TradingKey
Wed, Jul 23
Bitcoin Price Forecast: Trends and Investment Outlook from 2025 to 2030
From $0.01 in 2009 to $120,000+ in 2025, Bitcoin has evolved from obscurity to a globally recognized financial asset. While institutions and governments increasingly embrace it, investors must remain vigilant against volatility, security risks, and scams.TradingKey
Wed, Jul 16
